Bruker Daltonics Pioneers Ion Trap Accurate Mass Methods for Proteomics.Business Editors & Health/Medical Writers BIOWIRE2K ORLANDO, Fla.--(BW HealthWire)--June 3, 2002 At the American Society for Mass Spectrometry The American Society for Mass Spectrometry is a professional association based in the United States that supports the scientific field of mass spectrometry. As of 2007, the society had approximately 7000 members primarily from the US, but also from around the world. conference, Bruker Daltonics Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : BDAL BDAL Battle Doll Angelic Layer (game) ) today introduces AccuMass(TM), a new method for high mass accuracy protein identification on its esquire3000plus(TM) ion trap mass spectrometers. AccuMass improves both the mass accuracy of peptide mass fingerprints, and of MS/MS MS/MS Tandem Mass Spectroscopy MS/MS Multistage Mass Spectrometry peptide sequence data acquired on esquire3000plus systems significantly, to 0.05 Daltons and better. AccuMass allows the researcher to perform database searches with improved specificity due to better discrimination against false positives, while search times can be reduced fourfold. The combination of AccuMass with the superior scan power of the esquire3000plus, which resolves multiply-charged ions on-the-fly in standard scan mode at 13,000 amu/sec, makes the esquire3000plus the most powerful ion trap LC/MSn system for proteomics. For high-throughput environments, the esquire3000plus integrates into the Proteineer(TM) proteomics suite, combining automated sample preparation systems, mass spectrometry mass spectrometry or mass spectroscopy Analytic technique by which chemical substances are identified by sorting gaseous ions by mass using electric and magnetic fields. and bioinformatics. ABOUT BRUKER DALTONICS Bruker Daltonics is a leading developer and provider of innovative life science tools based on mass spectrometry. For more information about Bruker Daltonics, please visit www.bdal.com. CAUTIONARY STATEMENT Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to technological approaches, product development, manufacturing, market acceptance, cost and pricing of Bruker Daltonics' products, dependence on collaborative partners, suppliers, FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. and other regulatory approvals to the extent applicable, competition, the intellectual property of others, patent protection and litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. and other risk factors discussed from time to time in Bruker Daltonics' reports or filings with the Securities and Exchange Commission. Bruker Daltonics expressly disclaims any obligation to update the information contained herein. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion